Omeros Corporation (OMER) compared with its closest peers (ELTX, ATOS, GOVX, CYCN, DNTH): P/E 131.3 vs industry 17.2. Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Elicio Therapeutics, Atossa Therapeutics, GeoVax Labs, Cyclerion Therapeutics, Dianthus Therapeutics, Cocrystal Pharma, Oramed Pharmaceuticals, Sagimet Biosciences, Traws Pharma and Cartesian Therapeutics share Omeros's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | $68.07M | -3.1 |
| Atossa Therapeutics, Inc. (ATOS) | $24.85M | -0.1 |
| GeoVax Labs, Inc. (GOVX) | $5.31M | -0.0 |
| Cyclerion Therapeutics, Inc. (CYCN) | $21.21M | -1.1 |
| Dianthus Therapeutics, Inc. (DNTH) | $5.95B | -9.8 |
| Cocrystal Pharma, Inc. (COCP) | $22.25M | -1.2 |
| Oramed Pharmaceuticals Inc. (ORMP) | $210.48M | 4.1 |
| Sagimet Biosciences Inc. (SGMT) | $584.26M | -3.7 |
| Traws Pharma, Inc. (TRAW) | $8.57M | 1.4 |
| Cartesian Therapeutics, Inc. (RNAC) | $267.08M | -1.4 |
| Stock P/E | 131.3 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| vs Sector | 508.0% |
| vs Industry | 661.5% |
OMER overview · OMER earnings · OMER financials · OMER KPIs · OMER documents · OMER ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.